12-102843782-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 5 ACMG points: 5P and 0B. PP4_ModeratePM2PP3
This summary comes from the ClinGen Evidence Repository: The c.1066-3C>G variant in PAH has been reported in a Korean patient with PKU (BH4 deficiency excluded, PMID:15503242). This variant is absent from 1000G, ESP, ExAC and gnomAD. Multiple lines of computational evidence support a deleterious splicing effect (HSF, MaxENT). In summary, this variant meets criteria to be classified as uncertain significance for PAH. PAH-specific ACMG/AMP criteria applied: PP4_Moderate, PM2, PP3. LINK:https://erepo.genome.network/evrepo/ui/classification/CA16020928/MONDO:0009861/006
Frequency
Consequence
NM_000277.3 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PAH | NM_000277.3 | c.1066-3C>G | splice_region_variant, intron_variant | Intron 10 of 12 | ENST00000553106.6 | NP_000268.1 | ||
PAH | NM_001354304.2 | c.1066-3C>G | splice_region_variant, intron_variant | Intron 11 of 13 | NP_001341233.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome Cov.: 33
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Phenylketonuria Uncertain:1
The c.1066-3C>G variant in PAH has been reported in a Korean patient with PKU (BH4 deficiency excluded, PMID: 15503242). This variant is absent from 1000G, ESP, ExAC and gnomAD. Multiple lines of computational evidence support a deleterious splicing effect (HSF, MaxENT). In summary, this variant meets criteria to be classified as uncertain significance for PAH. PAH-specific ACMG/AMP criteria applied: PP4_Moderate, PM2, PP3. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.